Elismetrep

DRUG3 trials

Sponsors

Kallyope Inc.

Conditions

Acute MigraineMigraine

Phase 3

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

RecruitingNCT07645924

Kallyope Inc.Migraine

Start: 2026-07-01End: 2027-02-01Target: 1800Updated: 2026-08-20

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

RecruitingNCT07674654

Kallyope Inc.Acute Migraine

Start: 2026-08-03End: 2028-06-01Target: 1000Updated: 2026-08-27

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Not yet recruitingNCT07816367

Kallyope Inc.Migraine

Start: 2026-09-01End: 2027-12-01Target: 1500Updated: 2026-09-11